CD4 T cell dynamics shape the immune response to combination oncolytic herpes virus and BRAF inhibitor therapy for melanoma.
Bozhanova G, Hassan J, Appleton L, Jennings V, Foo S, McLaughlin M, Chan Wah Hak CM, Patin EC, Crespo-Rodriguez E, Baker G, Armstrong E, Chiu M, Pandha H, Samson A, Roulstone V, Kyula J, Vile R, Errington-Mais F, Pedersen M, Harrington K, Ono M, Melcher A.
Bozhanova G, et al. Among authors: hassan j.
J Immunother Cancer. 2022 Mar;10(3):e004410. doi: 10.1136/jitc-2021-004410.
J Immunother Cancer. 2022.
PMID: 35338089
Free PMC article.